These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 25055198

  • 1. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.
    Agarwal S, Fuentes-Orrego JM, Arnason T, Misdraji J, Jhaveri KS, Harisinghani M, Hahn PF.
    AJR Am J Roentgenol; 2014 Oct; 203(4):W408-14. PubMed ID: 25055198
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
    Bieze M, van den Esschert JW, Nio CY, Verheij J, Reitsma JB, Terpstra V, van Gulik TM, Phoa SS.
    AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ, Kim BS, Kim MJ, Kim SH, de Campos RO, Hernandes M, Semelka RC.
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [Abstract] [Full Text] [Related]

  • 6. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
    Portilha MA, Pedro MT, Ruivo C, Semedo LC, Marques C, Alves FC.
    Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
    [Abstract] [Full Text] [Related]

  • 7. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
    Roux M, Pigneur F, Calderaro J, Baranes L, Chiaradia M, Tselikas L, Decaens T, Costentin C, Laurent A, Azoulay D, Mallat A, Zafrani ES, Rahmouni A, Luciani A.
    J Magn Reson Imaging; 2015 Nov; 42(5):1249-58. PubMed ID: 25851028
    [Abstract] [Full Text] [Related]

  • 8. MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents.
    Thomeer MG, Willemssen FE, Biermann KK, El Addouli H, de Man RA, Ijzermans JN, Dwarkasing RS.
    J Magn Reson Imaging; 2014 May; 39(5):1259-64. PubMed ID: 23897798
    [Abstract] [Full Text] [Related]

  • 9. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis.
    Alamri TM, Cerny M, Al Shaikh M, Billiard JS, Olivié D, Chagnon M, Tang A.
    Abdom Radiol (NY); 2023 Mar; 48(3):874-885. PubMed ID: 36528729
    [Abstract] [Full Text] [Related]

  • 10. Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review.
    McInnes MD, Hibbert RM, Inácio JR, Schieda N.
    Radiology; 2015 Nov; 277(2):413-23. PubMed ID: 26020440
    [Abstract] [Full Text] [Related]

  • 11. Value of discrepancy of the central scar-like structure between dynamic CT and gadoxetate disodium-enhanced MRI in differentiation of focal nodular hyperplasia and hepatocellular adenoma.
    Park HJ, Byun JH, Kang JH, Kang HJ, Yu E, Lee SJ, Kim SY, Won HJ, Shin YM, Kim PN.
    Eur J Radiol; 2021 Jun; 139():109730. PubMed ID: 33930719
    [Abstract] [Full Text] [Related]

  • 12. Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?
    Roux M, Pigneur F, Baranes L, Calderaro J, Chiaradia M, Decaens T, Kastahian S, Charles-Nelson A, Tselikas L, Costentin C, Laurent A, Azoulay D, Mallat A, Rahmouni A, Luciani A.
    Abdom Radiol (NY); 2018 Jul; 43(7):1670-1681. PubMed ID: 29110059
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia.
    Cannella R, Rangaswamy B, Minervini MI, Borhani AA, Tsung A, Furlan A.
    AJR Am J Roentgenol; 2019 Mar; 212(3):538-546. PubMed ID: 30557050
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma.
    Bilreiro C, Soler JC, Ayuso JR, Caseiro-Alves F, Ayuso C.
    Radiol Med; 2021 Nov; 126(11):1379-1387. PubMed ID: 34287759
    [Abstract] [Full Text] [Related]

  • 18. Histopathologically confirmed focal nodular hyperplasia of the liver: gadoxetic acid-enhanced MRI characteristics.
    Grieser C, Steffen IG, Seehofer D, Kramme IB, Uktolseya R, Scheurig-Muenkler C, Hamm B, Denecke T.
    Magn Reson Imaging; 2013 Jun; 31(5):755-60. PubMed ID: 23219272
    [Abstract] [Full Text] [Related]

  • 19. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
    Sannier A, Cazejust J, Lequoy M, Cervera P, Scatton O, Rosmorduc O, Wendum D.
    Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.